Tech Portal Monaco: Press Releases

$Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma$

Feb. 27, 2026

Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma

GlobeNewswire

$Ipsen reçoit un avis positif du CHMP pour Ojemda® en monothérapie pour le traitement des enfants atteints de gliome pédiatrique de bas grade en rechute ou réfractaire, avec altération de BRAF$

Feb. 27, 2026

Ipsen reçoit un avis positif du CHMP pour Ojemda® en monothérapie pour le traitement des enfants atteints de gliome pédiatrique de bas grade en rechute ou réfractaire, avec altération de BRAF

GlobeNewswire

Feb. 27, 2026

Nominal Accelerates Naval Aviation Testing and Validation for Future Collaborative Combat Aircraft

GlobeNewswire

Feb. 27, 2026

Amneal Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Feb. 27, 2026

Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness

GlobeNewswire

Feb. 27, 2026

Communiqué de presse: L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif du CHMP comme traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil

GlobeNewswire

Feb. 27, 2026

Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform

GlobeNewswire

Aduro Clean Technologies nimmt an bevorstehenden Konferenzen und Handelsprogrammen teil

Feb. 27, 2026

Tech Portal Monaco: Press Releases

January 2026

February 2026

March 2026

Press releases published on February 27, 2026

Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment

X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome

Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging

ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE

Aurora Mobile Partners with China Post Securities to Deliver Millisecond Messaging and Enhance Digital Financial Services

Flare Therapeutics Presents Updated FX-909 Phase 1A Data in Late-Breaking Oral Presentation at 2026 ASCO Genitourinary Cancers Symposium

Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment

ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance

SourceDay Named to The Hackett Group’s 2025–2026 50 to Know List

Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma

Ipsen reçoit un avis positif du CHMP pour Ojemda® en monothérapie pour le traitement des enfants atteints de gliome pédiatrique de bas grade en rechute ou réfractaire, avec altération de BRAF

Nominal Accelerates Naval Aviation Testing and Validation for Future Collaborative Combat Aircraft

Amneal Reports Fourth Quarter and Full Year 2025 Financial Results

Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness

Communiqué de presse: L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif du CHMP comme traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil

Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform

Aduro Clean Technologies nimmt an bevorstehenden Konferenzen und Handelsprogrammen teil

Aduro Clean Technologies annonce sa participation à des conférences et à des programmes commerciaux

CUDIS Launches Sporty Series Ring with AI Coach and Integrated Access to Healthcare Providers

Clicks Brings Communicator to New Markets with Localized Keyboard Layouts